This inventor holds 1 USPTO granted patent. Top assignee: Altana Pharma Ag. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Paul-Georg Germann: Innovator in Respiratory Treatment
Introduction
Paul-Georg Germann is a notable inventor based in Lörrach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of respiratory disorders. His innovative approach combines established medical components to enhance patient care.
Latest Patents
Germann holds a patent for a groundbreaking pharmaceutical composition aimed at treating infant respiratory distress syndrome and acute lung injury. This patent, titled "Combination of C1-INH and lung surfactant for the treatment of respiratory disorders," incorporates C1 esterase inhibitor (C1-INH) and lung surfactant, which includes a lung surfactant protein. This innovative combination has the potential to improve outcomes for patients suffering from severe respiratory conditions.
Career Highlights
Throughout his career, Paul-Georg Germann has been associated with Altana Pharma AG, a prominent pharmaceutical company. His work at Altana has allowed him to focus on developing effective treatments that address critical health issues. Germann's dedication to research and innovation has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Germann has collaborated with esteemed colleagues, including Dietrich Häfner and Nils Ott. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, ultimately leading to advancements in respiratory treatment.
Conclusion
Paul-Georg Germann's contributions to the field of respiratory treatment through his innovative patent and collaborative efforts highlight his commitment to improving patient care. His work continues to inspire advancements in pharmaceutical research and development.